menu
    • menu

    Company profile for Chimeric Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease progression. To bring that promise to life for more patients, Chimeric’s world class team of cell therapy pioneers and experts is focused on the discovery, development and commercializat...
    Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease progression. To bring that promise to life for more patients, Chimeric’s world class team of cell therapy pioneers and experts is focused on the discovery, development and commercialization of the most innovative and promising cell therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Chimeric TherapeuticsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    62 Lygon St, LEVEL 3, Carlton, Victoria 3053
    Telephone
    Telephone
    +61 3 9824 5254
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://chimerictherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/chimeric-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Chimeric

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chimeric Announces FDA Clearance Of Ind Application For Chm 2101
    Chimeric Announces FDA Clearance Of Ind Application For Chm 2101

    31 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chimeric-therapeutics-announces-fda-clearance-of-ind-application-for-chm-2101-a-novel-cdh17-car-t-cell-therapy-for-advanced-gastrointestinal-cancers-301972303.html

    PR NEWSWIRE
    31 Oct 2023
    Share Share
    Chimeric Therapeutics To Attend BIO International Convention
    Chimeric Therapeutics To Attend BIO International Convention

    05 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/05/2681859/0/en/Chimeric-Therapeutics-To-Attend-BIO-International-Convention.html

    GLOBENEWSWIRE
    05 Jun 2023
    Share Share
    Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial
    Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial

    04 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/05/2681581/0/en/Chimeric-Announces-Launch-of-New-Phase-1B-Glioblastoma-Clinical-Trial.html

    GLOBENEWSWIRE
    04 Jun 2023
    Share Share
    Chimeric enters strategic manufacturing partnership with WuXi Advanced Therapies
    Chimeric enters strategic manufacturing partnership with WuXi Advanced Therapies

    11 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/12/2420535/0/en/Chimeric-enters-strategic-manufacturing-partnership-with-WuXi-Advanced-Therapies.html

    GLOBENEWSWIRE
    11 Apr 2022
    Share Share
    Chimeric Enters Clinical Partnership with Be The Match BioTherapies
    Chimeric Enters Clinical Partnership with Be The Match BioTherapies

    08 Mar 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-03-08/chimeric-enters-clinical-partnership-with-be-the-match-biotherapies/?widget=listSection

    CONTRACTPHARMA
    08 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search